Effectiveness of etodolac ('Lodine') compared with naproxen in patients with acute gout

Current Medical Research and Opinion
A MaccagnoA Romanowicz

Abstract

A double-blind, parallel group study was carried out in 61 patients suffering from acute gouty arthritis to compare the effectiveness of etodolac and naproxen in the relief of symptoms. Patients were allocated at random to receive either 300 mg etodolac twice daily (31 patients) or 500 mg naproxen twice daily (30 patients) for 7 days. Both groups were comparable for sex, age and weight of patients, but there was a tendency for patients in the etodolac group to have more severe gout as shown by baseline clinical assessment scores. The variables assessed on entry and on Days 2, 4 and 7 of treatment were pain intensity, swelling, tenderness, erythema, joint heat, range of motion, and physician's and patients' overall evaluation of the condition. The results showed that there was a significant improvement from baseline in all of the variables at each time point in both treatment groups. However, more etodolac-treated patients (81%) than naproxen-treated patients (53%) showed overall improvement at Day 2, and etodolac was significantly better than naproxen on the Day 2 evaluation of joint swelling and at the Day 4 evaluations of joint tenderness, range of motion and the physician's global assessment. At the final evaluation on Day 7...Continue Reading

References

Aug 25, 1979·The Medical Journal of Australia
Jan 1, 1974·Seminars in Arthritis and Rheumatism·S L Wallace
Jun 1, 1984·Journal of Oral and Maxillofacial Surgery : Official Journal of the American Association of Oral and Maxillofacial Surgeons·G W GastonJ E Frank
Jan 1, 1981·The Medical Clinics of North America·C T Marino, R A Greenwald

❮ Previous
Next ❯

Citations

Nov 1, 2008·Current Pain and Headache Reports·Brian S KirbyN Lawrence Edwards
Sep 6, 2012·Rheumatology·Lisa K Stamp, Peter T Chapman
May 19, 2006·Annals of the Rheumatic Diseases·W ZhangUNKNOWN EULAR Standing Committee for International Clinical Studies Including Therapeutics
Sep 7, 2005·Postgraduate Medical Journal·E Suresh
Jul 6, 2006·Arthritis Research & Therapy·Bruce N Cronstein, Robert Terkeltaub
Dec 8, 2010·AAPS PharmSciTech·Magdy M IbrahimMontasir A Fadlalla
Aug 5, 2011·Drugs & Aging·Lisa K Stamp, Sarah Jordan
Mar 13, 2014·Nature Reviews. Rheumatology·Frances ReesMichael Doherty
Mar 22, 2014·Seminars in Arthritis and Rheumatism·Puja P KhannaDinesh Khanna
Jul 16, 2003·Clinical Therapeutics·Karissa Y KimSheldon X Kong
Apr 8, 2014·Rheumatic Diseases Clinics of North America·Naomi Schlesinger
Oct 1, 2011·The Journal of Pain : Official Journal of the American Pain Society·Howard S SmithJoshua M Smith
Aug 19, 2011·The American Journal of Geriatric Pharmacotherapy·Michelle A Fravel, Michael E Ernst
May 24, 2006·Rheumatic Diseases Clinics of North America·Nancy Joseph-RidgePatricia MacDonald
Oct 25, 2006·The American Journal of Medicine·Joseph D Croft
Sep 19, 2006·Best Practice & Research. Clinical Rheumatology·Lan X Chen, H Ralph Schumacher
Dec 31, 2014·Expert Opinion on Pharmacotherapy·Philip C Robinson, Nicola Dalbeth
May 26, 2009·Expert Opinion on Pharmacotherapy·Naomi SchlesingerFernando Perez-Ruiz
Sep 17, 2014·The Cochrane Database of Systematic Reviews·Caroline M P G van DurmeRobert B M Landewé
Jun 8, 2018·Journal of Biomaterials Applications·Tomasz Z OsmałekMirosław Szybowicz
Dec 18, 2013·The Journal of Rheumatology·Nicola DalbethWilliam J Taylor
Jun 24, 2005·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·William N Jones, Michael J Maricic
Nov 24, 2007·BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy·F Perez-RuizA M Beites
Nov 2, 2005·Expert Opinion on Pharmacotherapy·Gregory Choy
Apr 17, 2008·Scandinavian Journal of Rheumatology·F Perez-Ruiz, N Schlesinger
Apr 22, 2008·The Cochrane Database of Systematic Reviews·H J E M JanssensE H Van de Lisdonk

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.